Our Pricing

Your First Week Starting Mounjaro Treatment

Published on: June 03, 2026

Understanding what happens during your Mounjaro first week UK treatment helps you prepare for the initial adjustment period and set realistic expectations. At Cured Pharmacy, our UK-registered clinical team guides patients through their first injection and beyond, with genuine Mounjaro KwikPens available from £124.99 following a free online consultation with a UK prescriber.

What Happens During Your Mounjaro First Week UK Treatment

Your first week on Mounjaro begins with the 2.5mg starter dose, which is specifically designed to help your body adjust to tirzepatide gradually. This lowest maintenance dose minimises gastrointestinal side effects whilst allowing the dual GIP/GLP-1 receptor mechanism to begin working [1]. You'll administer one subcutaneous injection per week, typically on the same day each week to maintain consistent therapeutic levels.

During this initial week, tirzepatide starts binding to GIP and GLP-1 receptors in your pancreas, gut, and brain. The medication slows gastric emptying and reduces appetite signals, though the full weight loss effects won't be apparent yet [1]. Most patients notice reduced hunger within 2-4 days of their first injection, but significant weight changes typically emerge after 4-8 weeks on the escalating dose schedule.

The 2.5mg starting dose is not intended for maximum weight loss—it's a tolerability dose. Clinical trials show that average weight reduction at this dose is modest, with greater effects appearing as you titrate up to maintenance doses of 10mg or 15mg over subsequent months [2]. Your UK prescriber will assess your response and tolerance before approving dose escalation every four weeks.

Mounjaro Week 1 Side Effects: What's Normal

Gastrointestinal side effects are the most common during your first week on Mounjaro. In the SURPASS clinical trials, approximately 20-25% of patients experienced mild to moderate nausea at the 2.5mg starting dose, with most symptoms resolving within 3-5 days [1][2]. Other typical first-week side effects include reduced appetite, mild abdominal discomfort, occasional loose stools, and temporary fatigue as your body adapts to the metabolic changes.

These side effects are generally less severe at the 2.5mg starting dose compared to higher maintenance doses. The graduated titration schedule used in UK clinical practice—starting at 2.5mg and increasing by 2.5mg every four weeks—significantly reduces the risk of severe gastrointestinal reactions compared to starting at higher doses [1]. Most patients find symptoms manageable without medication, though your prescriber may recommend anti-nausea strategies if needed.

Contact your prescriber immediately if you experience severe persistent vomiting, signs of pancreatitis (severe upper abdominal pain radiating to your back), allergic reactions, or visual changes. Whilst rare at the starting dose, these require clinical assessment. Mild injection site reactions—redness, slight swelling, or tenderness—affect approximately 5% of patients and typically resolve within 48 hours [2].

Managing First Week Discomfort

Eat smaller, more frequent meals rather than large portions. Avoid high-fat, greasy, or heavily spiced foods during your first week, as these can worsen nausea. Stay well hydrated—aim for 2-3 litres of water daily—as adequate hydration helps minimise constipation and supports the medication's metabolic effects. Many patients find ginger tea or peppermint helpful for mild nausea, though these are supportive measures rather than medical treatments.

Mounjaro Injection First Time: Step-by-Step Guidance

Your Mounjaro KwikPen arrives pre-filled and ready to use, with no mixing or preparation required. Before your first injection, remove the pen from the refrigerator and let it reach room temperature for 30 minutes—cold injections can be more uncomfortable. Wash your hands thoroughly and select an injection site: your abdomen (at least 5cm from your navel), upper thigh, or upper arm. Rotate sites weekly to prevent lipodystrophy (changes in fat tissue under the skin).

Remove the pen cap and check that the liquid is clear and colourless—do not use if it appears cloudy or discoloured. Clean your chosen injection site with an alcohol wipe and let it dry completely. Hold the pen at a 90-degree angle against your skin and press the injection button firmly until you hear a click. Keep the pen pressed against your skin for 5-10 seconds after the click to ensure the full dose is delivered [3]. You should see the dose indicator move to zero, confirming successful injection.

After injection, dispose of the used pen in a sharps container—never in household waste. Do not recap the pen. Slight bleeding at the injection site is normal; apply gentle pressure with a clean tissue if needed. The entire injection process takes less than 30 seconds once you're familiar with the technique. Your Cured Pharmacy clinical team provides detailed injection instructions with your first prescription, and our pharmacists are available by phone during business hours for additional support.

Starting Mounjaro Treatment UK: Realistic First Week Expectations

Weight loss during your first week on the 2.5mg starting dose is typically minimal—most patients lose 0.5-1.5kg, primarily from reduced food intake and initial water weight changes. The SURPASS trials showed that meaningful weight reduction begins after 4-8 weeks, with peak effects at maintenance doses of 10-15mg [1][2]. Expecting dramatic changes in week one sets unrealistic expectations and may lead to premature discontinuation.

What you will likely notice during your first week is appetite suppression. Many patients report feeling satisfied with smaller portions and experiencing fewer cravings between meals. This is tirzepatide's dual GIP/GLP-1 mechanism beginning to work—slowing gastric emptying and modulating appetite-regulating hormones in your brain [1]. These early appetite changes are positive indicators that the medication is working, even before significant weight loss appears on the scale.

Blood glucose improvements, if you have prediabetes or type 2 diabetes, may begin within the first week. Tirzepatide's insulin-sensitising effects start rapidly, though your prescriber will monitor glucose levels over several weeks before adjusting any concurrent diabetes medications. Non-diabetic patients won't experience hypoglycaemia at therapeutic doses, as tirzepatide's glucose-dependent mechanism only stimulates insulin when blood sugar is elevated [2].

Tracking Your Progress Safely

Weigh yourself once weekly at the same time of day, ideally first thing in the morning after using the toilet. Daily weighing during your first week can be misleading due to normal fluctuations in water retention, food volume, and bowel movements. Take body measurements (waist, hips, chest) and progress photos, as body composition changes may occur before significant scale movement. Keep a simple symptom diary noting appetite levels, side effects, and energy—this helps your prescriber assess your response and plan dose escalation appropriately.

Mounjaro 2.5mg Starting Dose UK: Why We Begin Low

The 2.5mg starting dose is mandated by the MHRA-approved Summary of Product Characteristics for Mounjaro in the UK. This graduated approach significantly reduces discontinuation rates due to gastrointestinal side effects compared to starting at higher doses [1]. Clinical evidence from the SURPASS programme demonstrates that the four-week titration schedule—2.5mg, 5mg, 7.5mg, 10mg, and optionally 15mg—optimises both tolerability and long-term adherence.

Starting low allows your body's GIP and GLP-1 receptors to upregulate gradually, your digestive system to adapt to slower gastric emptying, and your appetite-regulating neural pathways to recalibrate without overwhelming side effects. Patients who attempt to escalate doses faster than the recommended schedule experience significantly higher rates of nausea, vomiting, and treatment discontinuation [2]. The 2.5mg dose is not a therapeutic failure—it's a deliberate pharmacological strategy.

Your UK prescriber will not approve dose escalation before four weeks at each level, regardless of your tolerance. This is a safety requirement, not a suggestion. Rushing the titration increases your risk of pancreatitis, severe dehydration from vomiting, and other serious adverse events. The maximum licensed dose of 15mg is reached after 20 weeks on the standard escalation schedule—this timeline is based on extensive clinical trial data demonstrating optimal safety and efficacy [1][2].

What to Expect First Week Mounjaro: Lifestyle Considerations

Mounjaro works most effectively when combined with dietary modifications and increased physical activity, though dramatic lifestyle changes aren't necessary during your first week. Focus on eating balanced, nutrient-dense meals rather than restrictive dieting—your appetite will naturally decrease, making portion control easier. Prioritise lean proteins, vegetables, and whole grains, which are better tolerated than high-fat or heavily processed foods during the initial adjustment period.

Alcohol tolerance may decrease on Mounjaro due to slower gastric emptying and altered metabolism. Many patients report feeling intoxicated more quickly or experiencing worse hangovers. Limit alcohol during your first week whilst you assess your individual response. Alcohol also contains empty calories that can impede weight loss progress and may worsen gastrointestinal side effects like nausea.

Plan your first injection for a day when you can rest if needed—many patients schedule it for Friday evening or Saturday morning to allow weekend recovery if side effects occur. Avoid scheduling important events, travel, or physically demanding activities for 48 hours after your first injection until you know how your body responds. Most patients tolerate the 2.5mg dose well and maintain normal activities, but individual responses vary.

When to Contact Your Prescriber

Contact Cured Pharmacy's clinical team if you experience severe persistent vomiting (unable to keep down fluids for 24 hours), signs of pancreatitis (severe upper abdominal pain, especially if radiating to your back), allergic reactions (rash, swelling, difficulty breathing), significant visual changes, or symptoms of gallbladder disease (right upper abdominal pain, yellowing of skin or eyes). These require immediate clinical assessment. For general questions about mild side effects or injection technique, our pharmacists are available by phone at (+44) 116 4646009 during business hours.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. Retrieved from https://www.gov.uk/ [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes referenced from clinical trials represent average results and cannot be guaranteed for individual patients.